In this cluster, the expression of many AML tumor marker genes was unaffected by rapamycin, in contrast to other clusters where rapamycin suppressed the expression of these tumor genes (Supplementary Fig. 6a), including CTSK (Fig. 3d). Here, CTSK is linked to acute myeloid leukemia.